Mgmt quotes:
| Metric | Value | Speaker/Context |
|---|---|---|
| Q2 2025 Revenue | $107.7 million | CFO |
| Q2 Non-GAAP Gross Margin | 44.4% | CFO |
| Q2 Recurring Revenue % of Total | 63% | CFO |
| Q2 Operating Expenses | $47.7 million | CFO |
| Q2 Non-GAAP EPS | $0.02 | CFO |
| Q2 Cash Flow from Operations | $16 million | CFO |
| Q2 Cash and Investments (end of period) | $209 million | CFO |
| Q2 CapEx | $2.7 million | CFO |
| Q2 Test Cell Utilization | 75% | CEO |
| Q2 Eclipse Design Win Order | $28 million | CEO |
| Q2 New Customer Wins | $3.5 million | CEO |
| Q2 Software Bookings | $360,000 | CEO |
| Q2 Software ARR | $530,000 | CEO |
| Precision Analog Revenue Opportunity (Ultra-S) | ~$20 million | CEO |
| Q3 Revenue Guidance | ~$125 million (±$7 million) | CFO |
| Q3 Gross Margin Guidance | ~44% | CFO |
| Q3 Systems Revenue % Mix | 47% | CFO |
| Q3 Recurring Revenue % Mix | 53% | CFO |
| Q3 Operating Expenses Guidance | ~$50 million | CFO |
| Q3 Interest Income Net Guidance | ~$900,000 | CFO |
| Q3 Tax Provision Guidance | ~$15 million | CFO |
| Q4 2025 Effective Tax Rate Guidance | 30%–35% | CFO |
| Q3 Basic Share Count Guidance | ~46.8 million shares | CFO |
| Annual CapEx Target | $20 million | CFO |
| Remaining Share Repurchase Authorization | $23 million | CFO |